Clinical trial
Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy…
NCT00488449 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00488449 |
|---|---|
| Title | Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers |
| Official title | A Two-Part Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Oral Doses of GSK256073A, in a Randomized, Single-Blind, Dose Escalation Study in Healthy Adult Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Subjects, Dyslipidaemias |
| Intervention type | Drug |
| Interventions | GSK256073A tablets |
| Enrollment | 56 |
| Start date | Jun 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jun 20, 2007 |
| Last update posted | Jun 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: